Antiplatelet therapy in patients who received percutenous coronary intervention with concomitant hihg-ischemic risk

Not Applicable

Completed

• Conditions: Diseases of the circulatory system

• Registration Number: KCT0006445
• Lead Sponsor: Yonsei University Health System, Severance Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-10-27
• Last Update Posted: 18 September 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 3488

Inclusion Criteria

1. Age =50 years old
2. History of drug-eluting stent implantation due to acute myocardial infarction 12 to 24 months ago
3. High-risk for ischemic events (at least one of the following)
1) Age >65 years old
2) Medical treatments for diabetes mellitus
3) Multi-vessel coronary artery disease
4) More than 2 episodes of myocardial infarction
5) Chronic kidney disease (stage III or IV)

Exclusion Criteria

1. Age =85 years old
2. Pregant women or women with potential childbearing
3. Life expectancy < 1 year
4. Inability to understand or read the informed consent
5. Need for long-term anticoagulation therapy

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Composite of all-cause death, myocardial infarction, or stroke

Secondary Outcome Measures

Name	Time	Method
BARC type 2, 3, or 5 bleeding